Leap Therapeutics, Inc. (LPTX) Social Stream
LEAP THERAPEUTICS INC (LPTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LPTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-18 | 5 | $6 | $4 | $4.8 | $3.26 | 47.24% |
| 2022-01-21 | 5 | $6 | $4 | $5 | $3.26 | 53.37% |
| 2022-03-11 | 3 | $6 | $4 | $5 | $3.26 | 53.37% |
| 2022-05-16 | 4 | $6 | $4 | $5 | $3.26 | 53.37% |
| 2022-05-27 | 4 | $6 | $4 | $4.5 | $3.26 | 38.04% |
| 2022-07-13 | 4 | $6 | $3 | $4.25 | $3.26 | 30.37% |
| 2022-08-15 | 4 | $6 | $3.5 | $4.375 | $3.26 | 34.2% |
| 2022-11-16 | 3 | $4 | $2.5 | $3.5 | $3.26 | 7.36% |
| 2023-01-18 | 4 | $3 | $2.5 | $2.666 | $3.26 | -18.22% |
| 2023-01-27 | 4 | $3 | $2.5 | $2.75 | $3.26 | -15.64% |
| 2023-03-27 | 4 | $3 | $2 | $2.7 | $3.26 | -17.18% |
| 2023-05-16 | 4 | $3 | $2 | $2.5 | $3.26 | -23.31% |
| 2023-06-30 | 4 | $30 | $17 | $24.4 | $3.26 | 648.47% |
| 2023-07-13 | 4 | $30 | $18.5 | $24.7 | $3.26 | 657.67% |
| 2023-08-14 | 5 | $30 | $18.5 | $24.7 | $3.26 | 657.67% |
| 2023-11-14 | 5 | $21 | $7 | $15.3 | $3.26 | 369.33% |
| 2023-11-20 | 5 | $21 | $7 | $13.7 | $3.26 | 320.25% |
The Trend in the Analyst Price Target
Over the past 12 months, LPTX's average price target has gone up $10.2.
Over the past 44 weeks, LPTX's average upside potential has been 875.65%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 4 | 3 | 2.5 | 2.75 | 0.641 | 329.02% |
| 2023-03-27 | 4 | 3 | 2.5 | 2.80 | 0.290 | 865.52% |
| 2023-04-05 | 4 | 3 | 2.0 | 2.50 | 0.330 | 657.58% |
| 2023-11-14 | 5 | 21 | 7.0 | 15.30 | 1.560 | 880.77% |
| 2023-11-14 | 5 | 25 | 7.0 | 18.10 | 1.560 | 1060.26% |
LPTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 153 days, LPTX's average broker recommendation rating improved by 0.05.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how LEAP THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is higher than 241.34% of that group.
- To contextualize these metrics, consider that out of all US stocks, LEAP THERAPEUTICS INC's number of analysts covering the stock is greater than 344.51% of them.
- In the context of stocks in the micro market cap category, LEAP THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 842.32% of them.
- In terms of how LEAP THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -620.08% of that group.
Stocks similar to LEAP THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PULM, APVO, and NRBO.
View All Top Stocks by Price Target
Make investment decisions regarding LPTX using the data that counts. Try POWR Ratings for free.